91 related articles for article (PubMed ID: 17493758)
21. Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion.
Eftekhari S; Salvatore CA; Calamari A; Kane SA; Tajti J; Edvinsson L
Neuroscience; 2010 Aug; 169(2):683-96. PubMed ID: 20472035
[TBL] [Abstract][Full Text] [Related]
22. Global functions of extracellular, transmembrane and cytoplasmic domains of organic solute transporter β-subunit.
Christian WV; Hinkle PM
Biochem J; 2017 May; 474(12):1981-1992. PubMed ID: 28455390
[TBL] [Abstract][Full Text] [Related]
23. Antiapoptotic effect of calcitonin gene-related peptide on oxidative stress-induced injury in H9c2 cardiomyocytes via the RAMP1/CRLR complex.
Sueur S; Pesant M; Rochette L; Connat JL
J Mol Cell Cardiol; 2005 Dec; 39(6):955-63. PubMed ID: 16242145
[TBL] [Abstract][Full Text] [Related]
24. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
Ittner LM; Luessi F; Koller D; Born W; Fischer JA; Muff R
Biochem Biophys Res Commun; 2004 Jul; 319(4):1203-9. PubMed ID: 15194494
[TBL] [Abstract][Full Text] [Related]
25. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
[TBL] [Abstract][Full Text] [Related]
26. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
Thota C; Gangula PR; Dong YL; Yallampalli C
Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins.
Kuwasako K; Cao YN; Nagoshi Y; Tsuruda T; Kitamura K; Eto T
Mol Pharmacol; 2004 Jan; 65(1):207-13. PubMed ID: 14722252
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric analysis of the calcitonin receptor-like receptor domains responsible for cell-surface translocation of receptor activity-modifying proteins.
Kuwasako K; Kitamura K; Nagata S; Kato J
Biochem Biophys Res Commun; 2009 Jun; 384(2):249-54. PubMed ID: 19394311
[TBL] [Abstract][Full Text] [Related]
29. Ligand binding and activation of the CGRP receptor.
Conner AC; Simms J; Barwell J; Wheatley M; Poyner DR
Biochem Soc Trans; 2007 Aug; 35(Pt 4):729-32. PubMed ID: 17635135
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the structure of RAMP1 by mutagenesis and molecular modeling.
Simms J; Hay DL; Wheatley M; Poyner DR
Biophys J; 2006 Jul; 91(2):662-9. PubMed ID: 16632510
[TBL] [Abstract][Full Text] [Related]
31. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
[TBL] [Abstract][Full Text] [Related]
32. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3.
Muff R; Bühlmann N; Fischer JA; Born W
Endocrinology; 1999 Jun; 140(6):2924-7. PubMed ID: 10342886
[TBL] [Abstract][Full Text] [Related]
33. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs.
Sexton PM; Morfis M; Tilakaratne N; Hay DL; Udawela M; Christopoulos G; Christopoulos A
Ann N Y Acad Sci; 2006 Jul; 1070():90-104. PubMed ID: 16888151
[TBL] [Abstract][Full Text] [Related]
34. The gene expression of adrenomedullin, calcitonin-receptor-like receptor and receptor activity modifying proteins (RAMPs) in CCl4-induced rat liver cirrhosis.
Hwang IS; Tang F; Leung PP; Li YY; Fan ST; Luk JM
Regul Pept; 2006 Jul; 135(1-2):69-77. PubMed ID: 16713642
[TBL] [Abstract][Full Text] [Related]
35. Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat.
Pan ChS; Jiang W; Wu ShY; Zhao J; Pang YZ; Tang ChS; Qi YF
Basic Res Cardiol; 2006 May; 101(3):193-203. PubMed ID: 16450076
[TBL] [Abstract][Full Text] [Related]
36. Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).
Born W; Muff R; Fischer JA
Microsc Res Tech; 2002 Apr; 57(1):14-22. PubMed ID: 11921352
[TBL] [Abstract][Full Text] [Related]
37. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
Tardif M; Brouchon L; Rabiet MJ; Boulay F
Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
[TBL] [Abstract][Full Text] [Related]
38. Ramping it up: RAMP1 and the implications for migraine.
Russo AF
Pharmacogenomics; 2007 Jul; 8(7):687-90. PubMed ID: 18240900
[No Abstract] [Full Text] [Related]
39. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor.
Dey BR; Furlanetto RW; Nissley P
Biochem Biophys Res Commun; 2000 Nov; 278(1):38-43. PubMed ID: 11071852
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system.
Eftekhari S; Warfvinge K; Blixt FW; Edvinsson L
J Pain; 2013 Nov; 14(11):1289-303. PubMed ID: 23958278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
